Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. Rating: Mostly True (About this rating?) ...

Ozempic’s rise from diabetes treatment to cultural phenomenon has collided with a darker storyline: a growing wave of lawsuits from patients who say the drug cost them their sight. Plaintiffs across ...

Ozempic and similar weight loss drugs have been found to cut risks for a variety of health issues — ranging from heart to kidney disease — netting the pharma companies behind them billions of ...

DEC 15 (Reuters) - A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly alleging patients lost some or all of their eyesight while ...

Semaglutide is the active ingredient in Ozempic and Wegovy. It’s a synthetic form of GLP-1, a hormone that regulates our ...

Add Yahoo as a preferred source to see more of our stories on Google. A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman ...

Add Yahoo as a preferred source to see more of our stories on Google. On the Wednesday, January 28, 2026, episode of The Excerpt podcast: As GLP-1 use surges, lawsuits allege blindness, stomach ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

On the Wednesday, January 28, 2026, episode of The Excerpt podcast: As GLP-1 use surges, lawsuits allege blindness, stomach paralysis and more. USA TODAY Investigative Reporter Austin Fast breaks down ...